Vida Ventures Advisors, LLC
- SEC CIK
- 0001831423
- Latest filing
- Nov 3, 2025
Holdings in Q4 2022
Holdings as of Dec 31, 2022, filed Feb 8, 2023. Long positions only; changes compare share counts with Q3 2022.
- Positions
- 7
- −1 vs. Q3 2022
- Portfolio value
- $74.4M
- −$37.0M (−33.2%) vs. Q3 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| DYNDyne Therapeutics, Inc. | COM | 2,220,034 | $25.7M | 34.6% | 00.0% | Unchanged | History |
| KNTEKinnate Biopharma Inc. | COM | 2,207,772 | $13.5M | 18.1% | 00.0% | Unchanged | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 3,931,818 | $12.2M | 16.4% | 00.0% | Unchanged | History |
| ALLOAllogene Therapeutics, Inc. | COM | 1,798,163 | $11.3M | 15.2% | 00.0% | Unchanged | History |
| KRONKronos Bio, Inc. | COM | 2,765,314 | $4.48M | 6.0% | 00.0% | Unchanged | History |
| LIANYLianBio | SPONSORED ADS | 2,282,084 | $3.74M | 5.0% | 00.0% | Unchanged | History |
| PRAXPraxis Precision Medicines, Inc. | COM | 1,469,665 | $3.50M | 4.7% | −1,469,664−50.0% | Reduced | History |
Sold out since Q3 2022 (1)
Positions held at the end of Q3 2022 that are gone from this filing.